Black Friday$99$79 Baseline Health Check. Ends 1 DecGet my Baseline

Fasting insulin test: insulin resistance and results

Understand what a fasting insulin test can reveal, how it differs from glucose and HbA1c, and why HOMA-IR and symptoms need clinical interpretation.

Man drinking water in his kitchen before a morning fasting blood test
On this page

    In short

    • A fasting insulin test adds information about insulin resistance but cannot diagnose it alone, and there is no universal fasting insulin cut-off.
    • A typical lab range for fasting insulin is about 3 to 10 mIU/L, while Vively's optimal range is 3 to 5 mIU/L.
    • Of 4,579 Vively members with normal HbA1c and fasting glucose, 57% had fasting insulin above 5 mIU/L, against 16% above 10 mIU/L.

    From Vively member data

    57%
    Fasting insulin above 5 mIU/L
    members with normal HbA1c and fasting glucose

    16%
    Fasting insulin above 10 mIU/L
    above the typical lab range, same members

    4,579
    Members with normal blood sugar
    first blood tests, 2024 to 2026

    A fasting insulin test can add information about insulin resistance, but it cannot diagnose it on its own. Insulin can rise while glucose remains in range because the pancreas is compensating. Results need interpretation alongside fasting glucose, medical history and other risk factors; there is no universally accepted fasting insulin diagnostic cut-off.

    Fasting insulin ranges
    About 3 to 10mIU/LTypical lab range; labs set their own ranges, so use the range printed on your report
    3 to 5mIU/LVively optimal range, not a diagnostic threshold
    Same drawFasting glucose and insulin are paired for HOMA-IR

    These ranges help frame a conversation. A result outside a preferred range does not by itself establish a disease or show that treatment is needed.

    Checklist
    Prepare to review your insulin result
    This checklist organises information; it does not score your risk.

    What fasting insulin measures

    Fasting insulin measures the amount of insulin in the blood after a prescribed fast. Insulin is made by the pancreas and helps regulate glucose use and storage. A fasting result offers a snapshot under relatively standard conditions, rather than showing every insulin response to meals throughout the day.

    With insulin resistance, muscle, liver and fat tissue respond less effectively to insulin. The pancreas may compensate by producing more. This explains how glucose can remain within range even while insulin demand is higher. It does not mean that every person with a higher insulin result has the same cause or future risk.

    The fasting insulin test page explains the measurement in more detail. Interpretation depends on the circumstances of collection and the laboratory method. Insulin is a hormone, not a direct count of how resistant every tissue is to its effects.

    Video · 1:43

    Fasting insulin explained by Dr Michelle Woolhouse

    Dr Michelle Woolhouse, Vively Medical Director, explains why fasting insulin is worth testing, what high insulin does in the body, why it pairs with fasting glucose to give your HOMA-IR score, and why Vively uses an optimal range of 3 to 5 mIU/L.

    General information, not medical advice. Talk to your doctor about your own results.

    Fasting insulin, glucose and HbA1c answer different questions

    Glucose tests assess glucose, while an insulin test adds information about the hormone regulating it. A fasting glucose test measures glucose at collection. An HbA1c test reflects glucose exposure over a longer period, with limitations in some medical conditions.

    These are established tools for diabetes assessment. It would be misleading to say they only become useful after irreversible damage has occurred. A clinician uses the appropriate test, symptoms and history to identify glucose problems and decide whether confirmation or further investigation is needed.

    Fasting insulin may be useful in a broader assessment, but it is not a universally recommended replacement for glucose-based screening. The NIDDK explains that direct tests of insulin resistance are mainly used in research. In ordinary practice, clinicians often assess risk and related conditions without needing a definitive insulin-resistance measurement.

    What each result contributes
    MeasureUseful questionLimit
    Fasting glucoseWhat is glucose after the requested fast?One point in time; clinical confirmation may be needed
    HbA1cWhat is longer-term glucose exposure?Some blood and medical conditions affect interpretation
    Fasting insulinHow much insulin is present during the fast?No universal diagnostic cut-off
    HOMA-IRWhat does paired fasting glucose and insulin suggest?An estimate affected by the inputs and laboratory method
    These results are complementary. A clinician decides which tests are appropriate and what action follows.
    Woman smiling at her phone
    Bring the full laboratory report, including units and reference intervals, to your review.

    Why normal glucose can coexist with higher insulin

    Higher insulin production can compensate for reduced insulin sensitivity. As a result, glucose may remain within the laboratory range. This is one reason a clinician may look beyond glucose when assessing a person with relevant risk factors or a broader metabolic concern.

    However, this pattern does not justify predicting that someone will develop diabetes in a fixed number of years. The course differs between people and depends on several factors, including insulin production, genetics and other health conditions. Some people improve their risk profile, while others need ongoing treatment and monitoring.

    Symptoms such as fatigue or cravings cannot establish the pattern. They have many causes and can occur with normal laboratory results. A useful assessment keeps other explanations open instead of treating every symptom as evidence of high insulin.

    How to interpret your fasting insulin result

    Start with the unit and reference interval on your report, then consider the glucose result and your clinical history. Vively's optimal range is 3 to 5 mIU/L. A typical lab range is about 3 to 10 mIU/L, but labs set their own, so use the range printed on your report. These are reporting guides rather than universal diagnostic boundaries.

    A result above a preferred range can prompt discussion, but does not mean you should begin a supplement or restrict food without assessment. A low insulin result also needs context: it can have a different meaning depending on glucose and the person's health. Lower is not always better.

    Laboratory insulin methods are not fully interchangeable. A 2025 study on insulin measurement standardisation found substantial variation between methods, consistent with earlier research. When comparing results over time, discuss changes in laboratory or collection conditions before assuming the difference reflects a biological improvement or decline.

    Ask your clinician whether repeating the result would be useful and whether it would change management. Testing repeatedly without an interpretation plan can create anxiety around ordinary variation. The practical question is what the result adds to your care, not how often it can be measured.

    What HOMA-IR adds and where it falls short

    HOMA-IR is a calculation based on fasting glucose and fasting insulin from the same collection. It estimates insulin resistance under fasting conditions rather than directly measuring it. Our HOMA-IR calculator explains the inputs and units, and the HOMA-IR test page describes the clinical context.

    Do not combine glucose from one date with insulin from another or enter a non-fasting result as though it were fasting. Incorrect units can also produce a misleading answer. The number is only as useful as the quality and suitability of the inputs.

    HOMA estimates are affected by insulin assays, sampling and the model used. Research by Manley and colleagues demonstrated that these choices can materially change the estimate. There is no single threshold that works equally for every population, laboratory and medical situation, so the output should not be treated as a self-diagnosis.

    People using insulin or with conditions affecting insulin production need specialist interpretation. A calculator cannot determine whether its assumptions apply to them. Bring the original reports to a clinician rather than sharing only the calculated score.

    Prepare for testing and review the wider picture

    Follow the collection service's fasting instructions and ask how to take medicines beforehand. Do not change doses yourself or extend the fast to try to lower the result. Tell staff about any food, drinks or illness that may affect whether the collection meets the requested conditions.

    The broader review may include blood pressure, lipids, waist measurement where appropriate, sleep and family history. PCOS or previous gestational diabetes may also influence the assessment. A clinician selects investigations based on the person, rather than treating one insulin measurement as a complete metabolic check.

    Our guide to improving insulin sensitivity covers sustainable food and activity changes. These can be discussed while the assessment is underway. They do not require a promise that insulin resistance will disappear by a particular deadline.

    Couple having a picnic, one wearing a CGM
    Choose a practical plan that can fit ordinary meals and activity.

    CGM does not measure insulin resistance directly

    A sensor records glucose in fluid under the skin, not insulin. It can add context about meals and activity but cannot establish how much insulin was needed to produce a particular curve. A flat graph therefore does not prove normal insulin sensitivity.

    The glucose information hub explains meal responses and their limits. Consider the CGM program only when observing those patterns would answer a useful question. Abnormal or symptomatic results still need clinical assessment rather than further self-experimentation.

    How Vively can help

    Vively's Baseline Health Check includes fasting insulin alongside glucose-related and other blood markers. A practitioner helps interpret the pattern and plan appropriate next steps. The service supports preventative care and does not replace your GP's role in diagnosis or treatment.

    Review the pattern behind your results

    Explore a Baseline Health Check with practitioner support and a personal testing plan.

    Frequently asked questions

    Is fasting insulin the best early test for everyone?

    No single test is best for everyone. Fasting insulin can add context in selected assessments, but glucose and HbA1c remain established tests for diabetes screening and diagnosis. The appropriate choice depends on your history and the question being investigated. Ask how an additional result would change your care.

    Can normal HbA1c rule out insulin resistance?

    No. HbA1c measures glucose exposure, not insulin sensitivity, so compensated insulin resistance can coexist with a result in range. That does not make a normal HbA1c meaningless or automatically require more tests. A clinician assesses risk factors and other findings to decide whether further investigation is useful.

    Does a high fasting insulin result diagnose diabetes?

    No. Diabetes is assessed using glucose-related diagnostic criteria and clinical context, not a fasting insulin result alone. Higher insulin may prompt a broader review, but laboratory methods and other factors affect interpretation. Do not begin treatment or change prescribed medicines based solely on an insulin flag in a report.

    Can a CGM diagnose insulin resistance?

    No. A CGM measures glucose patterns and cannot show how much insulin your pancreas produced to achieve them. It may provide useful context for meals and activity, but does not replace appropriate laboratory testing or a clinical assessment. Repeated concerning readings should be discussed with a qualified health professional.

    Should I aim for the lowest insulin result possible?

    No. Insulin results must be interpreted alongside glucose, medical history and treatment. A low result is not automatically a better result, particularly when insulin production may be impaired. Focus on the clinician's explanation and an appropriate follow-up plan rather than trying to minimise a number through fasting or food restriction.

    Sources

    1. NIDDK: insulin resistance and prediabetes.
    2. RACGP: general practice management of type 2 diabetes.
    3. Insulin measurement standardisation study, 2025.
    4. Manley and colleagues: factors affecting HOMA estimates.
    5. Diabetes Australia: screening for type 2 diabetes.
    6. Healthdirect: fasting for medical tests.

    Know where you stand, and what to do about it.

    The Baseline Health Check is a blood test covering 70+ markers at one of 3,700+ collection centres. Your dietitian goes through your results with you and builds your plan. $99$79 this Black Friday, ends 1 Dec. Then $99 a month, cancel anytime.

    Every marker in range? Get your money back. T&Cs apply.
    Annia Soronio
    Annia SoronioMedical Writer

    Annia Soronio is Vively's Medical Researcher and Writer.

    Meet our team

    Start with a Baseline Health Check$99$79 Black Friday price, ends 1 Dec
    Get started
    glucose-management